Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive efficacy and safety results from the Phase 3 HERIZON-GEA-01 trial evaluating Ziihera® (zanidatamab-hrii) in combination with ...
Abstract: The purpose of the study that is reported in this paper is to develop a method to estimate the parameters of untransposed overhead transmission lines using synchronized measurements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback